A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease
Withdrawn before enrolling
Conditions studied: Type 2 Diabetes
In brief
The purpose of this research is to better understand how calcium and glucose may play a role in people developing diabetes. By doing this study, the investigator hopes to learn whether abnormal calcium and glucose responses in skin biopsies from healthy patients and patients with Type 2 diabetes can identify and predict patients at greatest risk for later complications.
Key facts
- Study ID
- NCT01917669
- Run by
- University of Kentucky
- People needed
- 0
- Starts
- 2013-10-01
- Expected to finish
- 2016-09-01
- Last updated by the study team
- 2016-10-25
Who can join
Age: 40 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy
- Type 2 Diabetes
You may not qualify if…
- Under 40 years of age
- Over 55 years of age
- Pregnant or breastfeedig
- Will not agree to a skin biopsy
- Talking calcium channel blockers
Where it is running
- University of Kentucky Center for Clinical and Translational Science — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.